New policy likely to resolve drug name anomaly

The government has geared up to resolve the confusion, restricting companies from using same brand names for different drugs. The health ministry has proposed to make an amendment in the Drugs and Cosmetics Rules.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Q7gasW
via IFTTT